WELL Health Technologies (TSE:WELL) Stock Price Expected to Rise, Scotiabank Analyst Says

WELL Health Technologies (TSE:WELL) had its price target increased by Scotiabank from C$6.00 to C$7.00 in a research report report published on Monday morning,BayStreet.CA reports.

Other analysts have also issued research reports about the stock. CIBC lifted their price target on shares of WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday. Haywood Securities upped their target price on shares of WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday. Finally, Ventum Financial decreased their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th.

WELL Health Technologies Trading Up 2.9 %

TSE:WELL opened at C$6.99 on Monday. The company has a debt-to-equity ratio of 41.57, a quick ratio of 1.02 and a current ratio of 1.25. WELL Health Technologies has a one year low of C$3.41 and a one year high of C$7.05. The business’s 50-day simple moving average is C$5.19 and its 200 day simple moving average is C$4.71. The stock has a market cap of C$1.74 billion, a price-to-earnings ratio of 12.26, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.